|
1.
|
Crabb DW: Pathogenesis of alcoholic liver
disease: newer mechanisms of injury. Keio J Med. 48:184–188. 1999.
View Article : Google Scholar : PubMed/NCBI
|
|
2.
|
Povero D, Busletta C, Novo E, et al: Liver
fibrosis: a dynamic and potentially reversible process. Histol
Histopathol. 25:1075–1091. 2010.PubMed/NCBI
|
|
3.
|
Svegliati Baroni G, D’Ambrosio L, Ferretti
G, et al: Fibrogenic effect of oridative stress on rat hepatic
stellate cells. Hepatology. 27:720–726. 1998.PubMed/NCBI
|
|
4.
|
Hellerbrand C, Stefanovic B, Giordano F,
Burchardt ER and Brenner DA: The role of TGF-β1 in initiating
hepatic stellate cell activation in vivo. J Hepatol. 30:77–87.
1999.
|
|
5.
|
Tsrkamoto H: Is interleukin 10
antifibrogenic in chronic liver injury? Hepatology. 28:1707–1709.
1998. View Article : Google Scholar : PubMed/NCBI
|
|
6.
|
Knittel T, Janneck T, Müller L, Fellmer P
and Ramadori G: Transforming growth factor beta 1-regulated gene
expression of Ito cells. Hepatology. 24:352–360. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
7.
|
Pinzani M, Milani S, Grappone C, Weber FL
Jr, Gentilini P and Abboud HE: Expression of platelet-derived
growth factor in model of acute liver injury. Hepatology.
19:701–707. 1994. View Article : Google Scholar : PubMed/NCBI
|
|
8.
|
Lasky JA, Ortiz LA, Tonthat B, et al:
Connective tissues growth factor mRNA expression is upregulated in
bleomycin-induced lung fibrosis. Am J Physiol. 275:L365–L371.
1998.PubMed/NCBI
|
|
9.
|
Abraham DJ, Shiwen X, Black CM, Sa S, Xu Y
and Leask A: Tumor necrosis factor alpha suppresses the induction
of connective tissue growth factor by transforming growth
factor-beta in normal and scleroderma fibroblasts. J Biol Chem.
275:15220–15225. 2000. View Article : Google Scholar
|
|
10.
|
Chen MM, Lam A, Abraham JA, Schreiner GF
and Joly AH: CTGF expression is induced by TGF- beta in cardiac
fibroblasts and cardiac myocytes: a potential role in heart
fibrosis. J Mot Cell Cardiol. 32:1805–1819. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
11.
|
Sato S, Nagaoka T, Hasegawa M, Tamatani T,
Nakanishi T, Takigawa M and Takehara K: Serum levels of connective
tissue growth factor are elevated in patients with systemic
sclerosis: association with extent of skin sclerosis and severity
of pulmonary fibrosis. J Rheumatol. 27:149–154. 2000.PubMed/NCBI
|
|
12.
|
Guo Y, Wang H and Zhang C: Establishment
of rat precision-cut fibrotic liver slice technique and its
application in verapamil metabolism. Clin Exp Pharmacol Physiol.
34:406–413. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
13.
|
Han DW, Ma XH and Zhao YC: Research of
animal model of hepatic cirrhosis. Shanxi Medical Journal. 4:1–5.
1979.(In Chinese).
|
|
14.
|
Xue KX, Yan HY and Liu TX:
Immunohistochemistry study on collagen type I and III of
sternomastoid muscle in congenital muscular torticollis. Journal of
Xinxiang Medical College. 22:530–532. 2005.(In Chinese).
|
|
15.
|
15. Han TL, Wang M, Hong M, et al: The
comparison and application of masson trichrome and he staining in
histological paraffin sections of teeth in guinea pig. China Animal
Husbandry & Veterinary Medicine. 38:55–57. 2011.(In
Chinese).
|
|
16.
|
Lei N, Zheng SZ and Lu Y: Mechanisms and
research progress of promoting blood circulation for removing blood
stasis herbs in treating hepatic fibrosis. China Journal of TCM and
Pharmacy. 25:265–268. 2010.(In Chinese).
|
|
17.
|
Yang Q, Feng YY and Jiang SL: Experiences
of professor Yao Xi-xian in treating chronic hepatic fibrosis based
on blood stasis theory. China Journal of TCM and Pharmacy.
22:168–171. 2007.(In Chinese).
|
|
18.
|
Luk JM, Zhang QS, Lee NP, et al: Hepatic
stellate cell-targeted delivery of M6P-HSA-glycyrrhetinic acid
attenuates hepatic fibrogenesis in a bile duct ligation rat model.
Liver Int. 27:548–557. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
19.
|
Constandinou C, Henderson N and Iredale
JP: Modeling liver fibrosis in rodents. Methods Mol Med.
117:237–250. 2005.PubMed/NCBI
|
|
20.
|
Saile B, Matthes N, Neubauer K, et al: Rat
liver myofibroblasts and hepatic stellate cells differ in
CD95-mediated apoptosis and response to TNF-alpha. Am J Physiol
Gastrointest Liver Physiol. 283:G435–G444. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
21.
|
Friedman SL: Molecular regulation of
hepatic fibrosis, an integrated cellular response to tissue injury.
J Biol Chem. 275:2247–2250. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
22.
|
Nieto N, Greenwel P, Friedman SL, Zhang F,
Dannenberg AJ and Cederbaum AI: Ethanol and arachidonic acid
increase alpha 2(I) collagen expression in rat hepatic stellate
cells overexpressing cytochrome P450 2E1. Role of
H2O2 and cyclooxygenase-2. J Biol Chem.
275:20136–20145. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
23.
|
Zhang C, Zhu Y, Wan J, Xu H, Shi H and Lu
X: Effects of Ginkgo biloba extract on cell proliferation,
cytokines and extracellular matrix of hepatic stellate cells. Liver
Int. 26:1283–1290. 2006.
|
|
24.
|
Kuriyama S, Yokoyama F, Inoue H, et al:
Sequential assessment of the intrahepatic expression of epidermal
growth factor and transforming growth factor-beta1 in
hepatofibrogenesis of a rat cirrhosis model. Int J Mol Med.
19:317–324. 2007.PubMed/NCBI
|
|
25.
|
Kaimori A, Potter J, Kaimori JY, Wang C,
Mezey E and Koteish A: Transforming growth factor-beta1 induces an
epithelial-to-mesenchymal transition state in mouse hepatocytes in
vitro. J Biol Chem. 282:22089–22101. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
26.
|
Gressner AM, Weiskirchen R, Breitkopf K
and Dooley S: Roles of TGF-beta in hepatic fibrosis. Front Biosci.
7:d793–d807. 2002. View
Article : Google Scholar : PubMed/NCBI
|
|
27.
|
Tamatani T, Kobayashi H, Tezuka K, et al:
Establishment of the enzyme-linked immunosorbent assay for
connective tissue growth factor (CTGF) and its detection in the
sera of biliary atresia. Biochem Biophys Res Commun. 251:748–752.
1998. View Article : Google Scholar : PubMed/NCBI
|
|
28.
|
Song SL, Gong ZJ, Zhang QR, Huang TX and
Wu SK: Changes and significance of cytokines and ultrastructure of
experimental hepatic fibrosis in rats. Chinese Journal of
Integrated Traditional and Western Medicine on Liver Diseases.
14:28–31. 2004.(In Chinese).
|
|
29.
|
McCartney-Francis NL and Wahl SM:
Transforming growth factor beta: a matter of life and death. J
Leukoc Biol. 55:401–409. 1994.PubMed/NCBI
|
|
30.
|
Saegusa S, Isaji S and Kawarada Y: Changes
in serum hyaluronic acid levels and expression of CD44 and CD44
mRNA in hepatic sinusoidal endothelial cells after major
hepatectomy in cirrhotic rats. World J Surg. 26:694–699. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
31.
|
Blom IE, Goldschmeding R and Leask A: Gene
regulation of connective tissue growth factor: new targets for
antifibrotic therapy? Matrix Biol. 21:473–482. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
32.
|
Chen YX, Lu CH, Xie WF, et al: Effects of
ribozyme targeting platelet-derived growth factor receptor beta
subunit gene on the proliferation and apoptosis of hepatic stellate
cells in vitro. Chin Med J (Engl). 118:982–988. 2005.PubMed/NCBI
|
|
33.
|
Yang L, Zhang CZ and Zhu QJ: Kangxian
ruangan keli inhibits hepatic stellate cell proliferation mediated
by PDGF. World J Gastroenterol. 9:2050–2053. 2003.PubMed/NCBI
|
|
34.
|
Guo J and Friedman SL: Hepatic
fibrogenesis. Semin Liver Dis. 27:413–426. 2007. View Article : Google Scholar
|
